TY  - JOUR
ID  - arxiv62501
KW  - COVID-19
KW  -  coagulation
KW  -  thrombosis
KW  -  blood clotting
KW  -  D-dimer
KW  -  endothelial dysfunction
KW  -  hypercoagulability
KW  -  cytokine storm.
UR  - https://mjstjournal.com/index.php/mjst/article/view/5060
Y1  - 2025/09/30/
AV  - none
A1  - Rohila, Umurzakova
N1  - Imported from MJST Journal (OAI id oai:ojs.pkp.sfu.ca:article/5060)
TI  - COVID AND CHANGES IN BLOOD CLOTTING
PB  - Center for Tech and Media Research
N2  - This article explores the relationship between COVID-19 infection and alterations in blood clotting mechanisms. Since the onset of the pandemic, clinical evidence has demonstrated that COVID-19 is not only a respiratory disease but also a systemic condition with significant hematological complications. Patients with severe forms of COVID-19 frequently exhibit abnormalities in coagulation, including increased risk of venous thromboembolism, disseminated intravascular coagulation (DIC), and microthrombi in vital organs. The article examines the underlying pathophysiological mechanisms, clinical manifestations, diagnostic challenges, and therapeutic strategies related to coagulation disorders in COVID-19. Particular attention is given to the role of endothelial dysfunction, hyperinflammatory response, and cytokine storm in promoting a hypercoagulable state.
JF  - Multidisciplinary Journal of Science and Technology
ER  -